<DOC>
	<DOCNO>NCT00379028</DOCNO>
	<brief_summary>The purpose study evaluate airway COPD patient , compare healthy volunteer , absorb steroid drug Symbicort Turbuhaler Seretide Diskus . The blood concentration steroid use surrogate marker .</brief_summary>
	<brief_title>Airway Clearance Study</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>COPD patient : ≥40 year age , Diagnosed COPD symptom ≥1 year , Prebronchodilatory FEV1 ≤55 % PN , Productive cough expectoration . Healthy volunteer : ≥18 year age , Healthy , Prebronchodilatory FEV1 &gt; 80 % PN , Nonsmoker COPD patient : Current respiratory tract disorder COPD , Asthma 40 year age , Significant unstable cardiovascular disorder , Healthy volunteer : Use regular medication therapy , Pregnancy breastfeeding ,</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>COPD</keyword>
</DOC>